Sponsor
The bill funds a rapid, independent DoD study to produce actionable data on bone-marrow shielding and radiation-response that could improve military and emergency preparedness, but its short timeline and military-focused setting may limit depth and civilian applicability and will incur modest taxpayer costs.
Military personnel and military medical planners would get evidence-based guidance on whether partial-body (bone marrow) shielding improves survival after gamma radiation exposure, informing protective-equipment choices and medical planning.
Public-health planners, first responders, and researchers would gain scientific data to refine radiation-response protocols and treatment priorities for Acute Radiation Syndrome, improving preparedness and response.
Congress would receive an independent, timely report (within 150 days) to support oversight and potential policy or procurement decisions related to radiation protection and response.
Because the study is centered at a military-affiliated research center, findings may be less generalizable to civilian healthcare and emergency settings, limiting usefulness for civilian preparedness without follow-up civilian studies.
A 150-day reporting deadline could constrain study depth and methodology, producing preliminary conclusions that require additional research before definitive guidance can be issued.
Taxpayers would bear additional costs for contracting the study and providing DoD administrative support.
Based on analysis of 2 sections of legislative text.
Requires DoD to contract a UARC to assess whether partial-body bone marrow shielding improves survivability after gamma radiation exposure and report to armed services committees within 150 days.
Representative · R-NE
Official title: To direct the Assistant Secretary of Defense for Nuclear, Chemical, and Biological Defense, Policy and Programs to seek to enter into an agreement with a University Affiliated Research Center affiliated with United States Strategic Command to conduct an independent scientific assessment with respect to bone marrow radiation shielding for nuclear survivability.
Introduced September 17, 2026 by Donald J. Bacon · Last progress September 17, 2026
Requires the Department of Defense to hire a University Affiliated Research Center tied to U.S. Strategic Command to conduct an independent scientific assessment of whether partial-body bone marrow shielding improves survivability after gamma radiation exposure. The study must review peer-reviewed literature, lab and experimental data addressing Acute Radiation Syndrome likelihood and severity and overall mortality, and the department must report results to congressional armed services committees within 150 days of enactment. The law is procedural and limited in scope: it creates a contracting and reporting requirement for a specific scientific assessment and does not itself change care protocols, authorize new medical programs, or appropriate funds beyond the contracting direction.